ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-15 Cr | ₹-16 Cr | ₹-17 Cr | ₹-17 Cr | ₹-18 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ABBOTT INDIA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-15 Cr |
| Mar2024 | ₹-16 Cr |
| Mar2023 | ₹-17 Cr |
| Mar2022 | ₹-17 Cr |
| Mar2021 | ₹-18 Cr |
How is Deferred Tax Assets / Liabilities of ABBOTT INDIA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-15 Cr | Negative | |
| Mar2024 | ₹-16 Cr | Negative | |
| Mar2023 | ₹-17 Cr | Negative | |
| Mar2022 | ₹-17 Cr | Negative | |
| Mar2021 | ₹-18 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹58,501.8 Cr | 4.8% | 2.7% | -7.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.1% | 4.7% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.7% | 2.5% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.1% | 7.6% | 45.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -0.4% | 6.3% | 14.7% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.3% | 0.3% | -8.9% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 4.8% |
2.7% |
-7.1% |
| SENSEX | -2.8% |
-2% |
7.3% |
You may also like the below Video Courses